𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiangiogenic and Antitumor Effects of a Protein Kinase Cβ Inhibitor in Human Breast Cancer and Ovarian Cancer Xenografts

✍ Scribed by Beverly A. Teicher; Krishna Menon; Enrique Alvarez; Chuan Shih; Margaret M. Faul

Book ID
110347049
Publisher
Springer US
Year
2002
Tongue
English
Weight
195 KB
Volume
20
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vivo antitumor effect of the mTOR inh
In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer
✍ Daisuke Ito; Koji Fujimoto; Tomohiko Mori; Kazuhiro Kami; Masayuki Koizumi; Eiji 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 459 KB

## Abstract Mammalian target of rapamycin (mTOR) is considered to be a major effector of cell growth and proliferation that controls protein synthesis through a large number of downstream targets. We investigated the expression of the phosphatidylinositol 3′‐kinase (PI3K)/mTOR signaling pathway in

Effects of tyrosine kinase inhibitors on
Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the RAS signaling pathway
✍ Jeffrey W. Clark; Anabela Santos-Moore; Lisa E. Stevenson; A. Raymond Frackelton 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 698 KB

Breast cancers frequently over-express a number of growth factor receptors. In addition, elevated src family kinase activity is present in a percentage of these neoplasms and has been implicated in signal transduction in these cells. Therefore, inhibiting tyrosine kinase activity is a potential appr